Is SLE many single-organ diseases or an overlapping spectrum?
- 5 May 2015
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Nature Reviews Rheumatology
- Vol. 11 (7), 385-386
- https://doi.org/10.1038/nrrheum.2015.61
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Treatment Algorithms in Systemic Lupus ErythematosusArthritis Care & Research, 2015
- Interferon-α-induced B-lymphocyte stimulator expression and mobilization in healthy and systemic lupus erthymatosus monocytesRheumatology, 2014
- Response to ‘T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?’ – Authors’ replyArthritis Research & Therapy, 2014
- T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?Arthritis Research & Therapy, 2014
- Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroidsAnnals Of The Rheumatic Diseases, 2013
- Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trialsAnnals Of The Rheumatic Diseases, 2012
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab studyArthritis & Rheumatism, 2012
- Cytokine disturbances in systemic lupus erythematosusArthritis Research & Therapy, 2011
- Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trialArthritis & Rheumatism, 2009